Categories that grew through frequent snacking occasions may see softening demand, while categories built around satiety, protein, and functional health may see sustained expansion
Specifically, high attained dose was associated with lower: all-cause mortality (RR = 0.42, P 25% group, with a mean patient-level change of 0.2% versus 0.8% relative to the pre-treatment baseline measurement ( P 25% weight loss group (126 mmHg versus 13 mmHg, P 25% weight loss group (75.4 mmHg versus 78.0 mmHg) and progressively larger patient-level declines relative to baseline across the different weight loss strata ( P = 0.002
Health Focus: Above all , Fat to Energy Conversion, Athletic Performance, & Endurance
These include the following: Nausea and vomiting (these are common during the first few weeks of starting the medication or when you escalate the dose during the titration phase) Bloating Feeling of fullness or early satiety Stomach ache Constipation Diarrhea (less common) These effects indicate that the medication has started working